D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.6B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 33.7% |
| 2 | Technology | 18.77% |
| 3 | Financials | 8.35% |
| 4 | Healthcare | 7.91% |
| 5 | Consumer Discretionary | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2376
ARC Group Acquisition I Corp
ARCL
$180M
| $4.54M | ﹤0.01% |
+460,000
| New | +$4.55M |
2026 Q2
0 quarters
|
|
2377
PUT
Cboe Global Markets
CBOE
$34.2B
| $4.53M | ﹤0.01% |
18,700
+7,000
| +60% | +$2.14M |
2026 Q1
1 quarter
|
|
2378
PUT
Constellation Brands
STZ
$23.5B
| $4.52M | ﹤0.01% |
32,500
-14,200
| -30% | -$2.11M |
2025 Q1
5 quarters
|
|
2379
Social Commerce Partners
SCPQ
$139M
| $4.51M | ﹤0.01% |
451,467
+49,967
| +12% | +$497K |
2026 Q1
1 quarter
|
|
2380
Archimedes Tech SPAC Partners III
ARCI
$354M
| $4.51M | ﹤0.01% |
450,500
+25,500
| +6% | +$253K |
2026 Q1
1 quarter
|
|
2381
OSI Systems
OSIS
$3.2B
| $4.51M | ﹤0.01% |
20,599
+13,314
| +183% | +$3.26M |
2021 Q2
20 quarters
|
|
2382
Gesher Acquisition Corp. II Class A Ordinary Shares
GSHR
$217M
| $4.5M | ﹤0.01% |
430,565
+120,000
| +39% | +$1.25M |
2025 Q2
4 quarters
|
|
2383
CALL
MasTec
MTZ
$13.8B
| $4.49M | ﹤0.01% |
+10,800
| New | +$4.13M |
2026 Q2
0 quarters
|
|
2384
Beam Therapeutics
BEAM
$2.54B
| $4.48M | ﹤0.01% |
+130,577
| New | +$3.94M |
2026 Q2
0 quarters
|
|
2385
Nurix Therapeutics
NRIX
$2.79B
| $4.48M | ﹤0.01% |
184,551
-159,652
| -46% | -$2.72M |
2026 Q1
1 quarter
|
|
2386
TGE Value Creative Solutions Corp
BEBE
$202M
| $4.48M | ﹤0.01% |
449,038
| – | – |
2026 Q1
1 quarter
|
|
2387
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.6B
| $4.47M | ﹤0.01% |
+37,606
| New | +$4.3M |
2026 Q2
0 quarters
|
|
2388
CALL
Evercore
EVR
$9.8B
| $4.47M | ﹤0.01% |
13,100
+2,500
| +24% | +$855K |
2024 Q4
6 quarters
|
|
2389
Sionna Therapeutics
SION
$172M
| $4.47M | ﹤0.01% |
+101,644
| New | +$4.07M |
2026 Q2
0 quarters
|
|
2390
PUT
Whirlpool
WHR
$1.88B
| $4.47M | ﹤0.01% |
113,400
+18,500
| +19% | +$867K |
2013 Q2
52 quarters
|
|
2391
Enterprise Financial Services Corp
EFSC
$2.18B
| $4.46M | ﹤0.01% |
67,731
+50,963
| +304% | +$3.06M |
2026 Q1
1 quarter
|
|
2392
PUT
argenx
ARGX
$55.1B
| $4.45M | ﹤0.01% |
4,800
-1,000
| -17% | -$825K |
2025 Q1
5 quarters
|
|
2393
CALL
Elevance Health
ELV
$96.6B
| $4.45M | ﹤0.01% |
11,500
+9,100
| +379% | +$3.37M |
2025 Q1
5 quarters
|
|
2394
First Trust Energy AlphaDEX Fund
FXN
$393M
| $4.44M | ﹤0.01% |
+219,719
| New | +$4.72M |
2026 Q2
0 quarters
|
|
2395
TechnipFMC
FTI
$26.2B
| $4.43M | ﹤0.01% |
66,848
-28,527
| -30% | -$2.02M |
2023 Q4
10 quarters
|
|
2396
CALL
Fidelity National Information Services
FIS
$19.7B
| $4.42M | ﹤0.01% |
+113,700
| New | +$4.92M |
2026 Q2
0 quarters
|
|
2397
BGC Group
BGC
$5.54B
| $4.42M | ﹤0.01% |
413,136
-1,007,516
| -71% | -$11.3M |
2024 Q2
8 quarters
|
|
2398
National Healthcare Properties, Inc. Common Stock
NHP
$1.15B
| $4.4M | ﹤0.01% |
+300,558
| New | +$4.21M |
2026 Q2
0 quarters
|
|
2399
New Providence Acquisition Corp III
NPAC
$404M
| $4.39M | ﹤0.01% |
422,861
+322,861
| +323% | +$3.34M |
2025 Q3
3 quarters
|
|
2400
Corsair Gaming
CRSR
$1.48B
| $4.38M | ﹤0.01% |
453,419
-995,832
| -69% | -$7.71M |
2023 Q2
12 quarters
|
|
Similar funds
D.E. Shaw & Co's Q2 2026 Portfolio in Review
As of Q2 2026, D.E. Shaw & Co held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
D.E. Shaw & Co deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- D.E. Shaw & Co's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
- D.E. Shaw & Co's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- D.E. Shaw & Co fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- D.E. Shaw & Co's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- D.E. Shaw & Co opened 872 new positions and closed 527 in Q2 2026.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.